SPADARO, Aldo
 Distribuzione geografica
Continente #
EU - Europa 2.112
NA - Nord America 1.601
AS - Asia 880
SA - Sud America 289
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 2
Totale 4.918
Nazione #
US - Stati Uniti d'America 1.573
RU - Federazione Russa 1.143
SG - Singapore 373
BR - Brasile 258
CN - Cina 251
IE - Irlanda 245
SE - Svezia 238
DE - Germania 123
UA - Ucraina 105
HK - Hong Kong 103
GB - Regno Unito 60
FR - Francia 59
FI - Finlandia 58
VN - Vietnam 52
IN - India 30
IT - Italia 24
BE - Belgio 18
CA - Canada 17
BD - Bangladesh 14
AR - Argentina 12
TR - Turchia 9
PK - Pakistan 8
UZ - Uzbekistan 8
ZA - Sudafrica 7
AT - Austria 6
ES - Italia 6
IQ - Iraq 6
AZ - Azerbaigian 5
CO - Colombia 5
KE - Kenya 5
MX - Messico 5
VE - Venezuela 5
MA - Marocco 4
PL - Polonia 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
IR - Iran 3
LT - Lituania 3
TN - Tunisia 3
AL - Albania 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
EE - Estonia 2
JP - Giappone 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BI - Burundi 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
NL - Olanda 1
NR - Nauru 1
NZ - Nuova Zelanda 1
RO - Romania 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.909
Città #
Moscow 328
Dublin 245
Jacksonville 214
Singapore 178
Chandler 176
Ashburn 175
Nyköping 127
Beijing 126
Dallas 109
Hong Kong 103
San Jose 89
The Dalles 75
Ann Arbor 67
Los Angeles 58
Munich 42
Cambridge 38
Princeton 37
Lauterbourg 34
Des Moines 31
Medford 30
Lancaster 26
São Paulo 25
Boardman 23
Council Bluffs 23
Dearborn 22
Woodbridge 20
Brussels 18
Ho Chi Minh City 18
Buffalo 16
Chennai 13
San Mateo 12
Tianjin 12
Hanoi 10
Jinan 10
Pune 10
Chicago 9
Frankfurt am Main 9
Belo Horizonte 8
Helsinki 8
New York 8
Tashkent 8
Redondo Beach 7
Rio de Janeiro 7
Turku 7
Brooklyn 6
Düsseldorf 6
Espoo 6
London 6
Montreal 6
Porto Alegre 6
Santa Clara 6
Baku 5
Mountain View 5
Nairobi 5
Salvador 5
San Francisco 5
Boston 4
Changsha 4
Haikou 4
Istanbul 4
Lahore 4
Manchester 4
Orem 4
Pelotas 4
Poplar 4
Shanghai 4
Stockholm 4
Atlanta 3
Caruaru 3
Contagem 3
Curitiba 3
Guangzhou 3
Hangzhou 3
Hải Dương 3
Itapevi 3
Joinville 3
Nanjing 3
Ningbo 3
Norwalk 3
Osasco 3
Phoenix 3
Recife 3
Salerno 3
Santo André 3
Seattle 3
Taizhou 3
Toronto 3
Warsaw 3
Washington 3
Wilmington 3
Abidjan 2
Almaty 2
Aparecida de Goiânia 2
Auburn Hills 2
Baghdad 2
Berlin 2
Betim 2
Blumenau 2
Bolzano 2
Brasília 2
Totale 2.811
Nome #
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 198
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder. 193
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: Effect of treatment with recombinant alpha interferon 172
Serum thrombopoietin in chronic liver disease: Relation to severity of the disease and spleen size 166
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 162
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 161
Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C 153
HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE 150
[Behavior of anti-HBc IgM in acute and chronic hepatitis]. 148
Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up 146
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B. 145
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 144
Ten year follow-up of patients with chronic hepatitis C treated with interferon 144
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 141
FOCAL LYMPHOCYTIC AGGREGATES IN CHRONIC HEPATITIS-C - OCCURRENCE, IMMUNOHISTOCHEMICAL CHARACTERIZATION, AND RELATION TO MARKERS OF AUTOIMMUNITY 139
Current practice of hepatitis C treatment in Southern Italy. 138
Randomised trial of two different daily doses of interferon- alpha versus classical therapy in treatment-naive patients with chronic hepatitis C 135
Clinical Outcome of HBeAg-Negative Chronic Hepatitis B in Relation to Virological Response to Lamivudine 132
Does malnutrition affect survival in cirrhosis? 132
PREVALENCE OF ANTI-HCV ANTIBODIES IN PATIENTS WITH CHRONIC LIVER-DISEASE AND ITS RELATIONSHIP TO HBV AND HDV INFECTIONS 129
NON-ALCOHOLIC FATTY LIVER DISEASE: A MULTICENTRE CLINICAL STUDY BY THE ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER 128
High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. 128
Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis 126
Current practice of hepatitis C treatment in Southern Italy. 126
Farmaci di più comune uso in gastroenterologia 125
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. 125
FULMINANT HEPATIC FAILURE AND AUTOIMMUNE DISORDERS IN PATIENT WITH MULTIPLE SCLEROSIS ON INTERFERON BETA 1A: A FATAL COMBINATION? 121
Cultural representation of newborn feeding 116
Current practice of chronic hepatitis B treatment in Southern Italy. 114
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data 99
Toxicity of IFN plus ribavirin in patients with chronic hepatitis C. A multicenter retrospective study 99
High Serum Resistin in Chronic Viral Hepatitis Is not a Marker of Metabolic Disorder 88
Randomized trial of two different daily doses of alpha-interferon versus classical treatment in naive patients with chronic hepatitis C 85
Re-treatment with interferon plus ribavirin of chronic hepatitis C nonresponders to interferon monotherapy: A meta- analysis of individual patient data 84
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial. 83
Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C 81
Terapia dell'epatite cronica C: 10 anni di esperienze 81
null 81
Totale 4.918
Categoria #
all - tutte 15.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022238 0 30 5 14 14 3 8 7 4 42 41 70
2022/2023698 48 64 51 35 62 66 7 52 284 5 19 5
2023/2024161 7 32 10 21 16 45 8 16 0 1 0 5
2024/2025829 4 21 14 65 8 19 21 206 175 50 90 156
2025/20262.197 111 117 127 88 172 494 272 326 335 82 37 36
2026/202731 28 3 0 0 0 0 0 0 0 0 0 0
Totale 4.918